Areas of Expertise
Ellie joined IMS P&R in 2005 as an Analyst and has recently been promoted to Consultant. Projects she has been involved with include:
-
Price and positioning strategy for a novel hepatitis B drug
-
Price sensitivity analysis for a novel anti-fungal agent
-
Study to improve market access within the EU
-
Multiple EU supply chain management projects
-
Designing a budget impact model for an anti-psychotic agent
-
Market access strategy for a new cartilage repair product
Other therapy areas in which she has conducted projects include:
-
Osteoporosis
-
Cardiovascular
-
Bone metastases
-
Anti-infectives
Before Joining IMS P&R
Ellie worked for KS Biomedix, assisting with the management of clinical trial programs for novel arthritis and oncology products. She also worked as part of the NHS modernisation support team, helping to develop frameworks to improve the efficiency of operating theatre utilisation.
Education
-
PhD, Genetics, University of Cambridge
-
Her PhD was carried out in collaboration with a spin-out company from the university, and focused on identifying new antibacterial drug targets
-
-
BSc, Biochemistry, University of Birmingham